38.80 USD
↗ 0.18 (0.47%)AT CLOSE (11:59 AM EDT)
Novo-Nordisk A/S
NVONYSE • USD
38.81
↗ 0.01 (0.02%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
38.81
↗ 0.01 (0.02%)
Market: CLOSED
NVO is currently priced at $38.80. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 25, 2026.
Open?$38.81
High?$38.83
Low?$38.41
Prev. Close?$38.62
Volume?10.2M
Avg. Volume?N/A
VWAP?$38.64
Bid / Ask
Bid?$38.77 × 100
Ask?$38.82 × 1.6K
Spread?$0.05
Midpoint?$38.80
Valuation & Ratios
Market Cap?171.4B
Shares Out?3.4B
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?26.3M
Days to Cover?2.9
Avg Daily Volume9.0M
Settlement Date2026-09-15